Collagen-based three-dimensional culture microenvironment promotes epithelial to mesenchymal transition and drug resistance of human ovarian cancer in vitro
Open accessAbstract
model to better understand the manifold mechanisms of OvCa metastasis and also provide a robust tool for screening new anti-ovarian cancer therapeutics.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Encapsulation of human ovarian cancer cell lines derived from primary tumors in collagen-I hydrogels showed enhanced mesenchymal traits, invasiveness and drug resistance.
“Encapsulation of human ovarian cancer cell lines derived from primary tumors in collagen-I hydrogels showed enhanced mesenchymal traits, invasiveness and drug resistance (Liu et al., 2018).”
From Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine (2022) · cites this paper as Liu et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712 · see citing works
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · see citing works
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,632 · see citing works
Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.
Yang, J., & Weinberg, R. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,135 · see citing works
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272 · see citing works
Molecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,813 · see citing works
Kurrey, N. K., Jalgaonkar, S. P., Joglekar, A. V., Ghanate, A. D., Chaskar, P. D., Doiphode, R. Y., & Bapat, S. A. (2009) · Stem Cells · doi:10.1002/stem.154 · Cited by 655 · see citing works
Haslehurst, A., Koti, M., Dharsee, M., Nuin, P. A. S., Evans, K., Geraci, J., Childs, T. J., Chen, J., Li, J., Weberpals, J. I., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-91 · Cited by 402 · see citing works
Zhang, K., Corsa, C. A. S., Ponik, S. M., Prior, J. L., Piwnica-Worms, D. R., Eliceiri, K. W., Keely, P. J., & Longmore, G. D. (2013) · Nature Cell Biology · doi:10.1038/ncb2743 · Cited by 393 · see citing works
Interstitial collagenases as markers of tumor progression.
Brinckerhoff, C., Rutter, J. L., & Benbow, U. (2000) · PubMed · Cited by 333 · see citing works
Tellez, C. S., Juri, D. E., Do, K., Bernauer, A. M., Thomas, C. L., Damiani, L. A., Tessema, M., Leng, S., & Belinsky, S. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3035 · Cited by 277 · see citing works
Integrin α5β1 facilitates cancer cell invasion through enhanced contractile forces
Mierke, C. T., Frey, B., Fellner, M., i, M. H., & Fabry, B. (2011) · Journal of Cell Science · doi:10.1242/jcs.071985 · Cited by 268 · see citing works
Shintani, Y., Maeda, M., Chaika, N. V., Johnson, K. R., & Wheelock, M. J. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0071oc · Cited by 259 · see citing works
Modeling Ewing sarcoma tumors in vitro with 3D scaffolds
Fong, E. L. S., Lamhamedi-Cherradi, S.-E., Burdett, E., Ramamoorthy, V., Lazar, A. J., Kasper, F. K., Farach‐Carson, M. C., Vishwamitra, D., Demicco, E. G., Menegaz, B. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221403110 · Cited by 238 · see citing works
Wever, O. D., Pauwels, P., Craene, B. D., Sabbah, M., Emami, S., Redeuilh, G., Gespach, C. P., Bracke, M., & Berx, G. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0464-1 · Cited by 229 · see citing works
Shintani, Y., Hollingsworth, M. A., Wheelock, M. J., & Johnson, K. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2322 · Cited by 221 · see citing works
Menke, A., Philippi, C., Vogelmann, R., Seidel, B., Lutz, M. P., Adler, G., & Wedlich, D. (2001) · PubMed · Cited by 196 · see citing works
Tumor cell invasiveness correlates with changes in integrin expression and localization
Macho‐Maschler, S., Wirl, G., Spring, H., Bredow, D. V., Sordat, I., Beug, H., & Ernst Reichmann, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208423 · Cited by 190 · see citing works
Marchini, S., Fruscio, R., Clivio, L., Beltrame, L., Porcu, L., Nerini, I. F., Cavalieri, D., Chiorino, G., Cattoretti, G., Mangioni, C., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.026 · Cited by 176 · see citing works
A 3D Fibrous Scaffold Inducing Tumoroids: A Platform for Anticancer Drug Development
Girard, Y., Wang, C., Ravi, S., Howell, M., Mallela, J. P., Alibrahim, M., Green, R. J., Hellermann, G., Mohapatra, S. S., & Mohapatra, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075345 · Cited by 134 · see citing works
Grzesiak, J. J., & Bouvet, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603088 · Cited by 119 · see citing works
Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
Deng, J., Wang, L., Chen, H., Hao, J., Ni, J., Chang, L., Duan, W., Graham, P., & Li, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9908 · Cited by 115 · see citing works
Sodek, K. L., Brown, T. J., & Ringuette, M. J. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-223 · Cited by 111 · see citing works
Chen, Q., Jiao, D., Wang, J., Hu, H., Tang, X., Chen, J., Mou, H., & Lu, W. (2016) · Oncotarget · doi:10.18632/oncotarget.8229 · Cited by 100 · see citing works
Composition of the extracellular matrix of the peritoneum
Witz, C. (2001) · Journal of the Society for Gynecologic Investigation · doi:10.1016/s1071-5576(01)00122-8 · Cited by 96 · see citing works
Huang, Y.-J., & Hsu, S. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.09.010 · Cited by 77 · see citing works
Wang, X., Wang, W., Ma, J., et al. (2006) · Biotechnology Progress · doi:10.1021/bp050386n · Cited by 75 · see citing works
Self-citationMiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2
Zhao, H., Yu, X., Ding, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10736 · Cited by 75 · see citing works
Zhao, H., LIU, S., Wang, G., WU, X., Ding, Y., Guo, G., Jiang, J., & Cui, S. (2014) · Oncology Reports · doi:10.3892/or.2014.3640 · Cited by 71 · see citing works
Zhao, H., BI, T., Qu, Z., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3311 · Cited by 64 · see citing works
Effect of microRNA-206 on Cytoskeleton Remodelling by Downregulating Cdc42 in MDA-MB-231 Cells
Liu, H., Cao, Y., Ye, W., & Sun, Y. (2010) · Tumori Journal · doi:10.1177/030089161009600518 · Cited by 60 · see citing works
Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma
Barbolina, M. V., Adley, B. P., Kelly, D. L., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.25 · Cited by 58 · see citing works
Sabe, H. (2011) · The Journal of Biochemistry · doi:10.1093/jb/mvr044 · Cited by 58 · see citing works
Zhu, G., Risteli, J., Puistola, U., Kauppila, A., & Risteli, L. (1993) · PubMed · Cited by 52 · see citing works
Quiros, R. M., Valianou, M., Kwon, Y., Brown, K. M., Godwin, A. K., & Cukierman, E. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.03.006 · Cited by 52 · see citing works
Alsibai, K. D., & Meseure, D. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24548 · Cited by 51 · see citing works
Davidson, B., Goldberg, I., Gotlieb, W. H., Kopolovic, J., Risberg, B. Å., Ben‐Baruch, G., & Reich, R. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1022272204045 · Cited by 50 · see citing works
Han, H., & Hsu, S. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.06.014 · Cited by 45 · see citing works
Shen, Y., Shen, R., Ge, L., Zhu, Q., & Li, F. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e318263ef34 · Cited by 38 · see citing works
Main, H. G., Yu, Y., Choi, J. J., Kajdacsy‐Balla, A., & Barbolina, M. V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16023419 · Cited by 37 · see citing works
Guzman, A., Alemany, V. S., Nguyen, Y. T.-K., Zhang, C. R., & Kaufman, L. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.014 · Cited by 37 · see citing works
Self-citationNeoangiogenesis: A putative marker of malignancy in non-small-cell-lung-cancer (NSCLC) development
Fontanini, G., Vignati, S., Bigini, D., Lucchi, M., Mussi, A., Basolo, F., Angeletti, C. A., & Bevilacqua, G. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960904)67:5 · Cited by 34 · see citing works
Composition of the Extracellular Matrix of the Peritoneum
Witz, C. A., Montoya-Rodriguez, I. A., Cho, S., Centonze, V. E., Bonewald, L. F., & Schenken, R. S. (2001) · Journal of the Society for Gynecologic Investigation · doi:10.1177/107155760100800508 · Cited by 24 · see citing works
Isolation of Mammary Epithelial Cells from Three-dimensional Mixed-cell Spheroid Co-culture
Xu, K., & Buchsbaum, R. J. (2012) · Journal of Visualized Experiments · doi:10.3791/3760 · Cited by 16 · see citing works
Ukaji, T., Lin, Y., Banno, K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137663 · Cited by 12 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Brinckerhoff C. E. Rutter J. L. Benbow U. Clin. Cancer Res. 2000 6 4823 4830 11156241
- Zhu G. G. Risteli J. Puistola U. Kauppila A. Risteli L. Cancer Res. 1993 53 5028 5032 8402695
- Menke A. Philippi C. Vogelmann R. Seidel B. Lutz M. P. Adler G. Wedlich D. Cancer Res. 2001 61 3508 3517 11309315
Cited by
Sorted by citations
Yee, C., Dickson, K.-A., Muntasir, M. N., Ma, Y., & Marsh, D. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.836984 · Cited by 66 · see citing works
An omentum-inspired 3d peg hydrogel for identifying ecm-drivers of drug resistant ovarian cancer
Brooks, E. A., Gencoglu, M. F., Corbett, D. C., Stevens, K. R., & Peyton, S. R. (2019) · APL Bioengineering · doi:10.1063/1.5091713 · Cited by 51 · see citing works
- Authors
- Liu, M., Zhang, X., Long, C., Xu, H., Cheng, X., Chang, J., Zhang, C., Zhang, C., & Wang, X.
- Affiliations
- Dalian Medical University (CN)
- Corresponding author
- Wang, Xiuli
- ORCID
- Venue
- RSC Advances
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2018
- Volume
- 8
- Issue
- 16
- Pages
- 8910-8919
- ISSN
- 2046-2069 (ISSN-L)
- PMC
- PMC9078576
- OpenAlex
- W2789183775
- Cited by
- 48
- References
- 45
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 6 · 2023: 7 · 2022: 9 · 2021: 5 · 2020: 4 · 2019: 2 · 2018: 1
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- RSC Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31470952, 31771068)
- Natural Science Foundation of Liaoning Province (2014023003)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- epithelial-mesenchymal transition, drug resistance, ovarian cancer, tumor microenvironment, metastasis, in vitro model
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review